Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

1.

Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation.

Russ BE, Olshanksy M, Smallwood HS, Li J, Denton AE, Prier JE, Stock AT, Croom HA, Cullen JG, Nguyen ML, Rowe S, Olson MR, Finkelstein DB, Kelso A, Thomas PG, Speed TP, Rao S, Turner SJ.

Immunity. 2014 Nov 20;41(5):853-65. doi: 10.1016/j.immuni.2014.11.001. Epub 2014 Nov 6.

PMID:
25517617
2.

Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness.

Schultz-Cherry S, Webby RJ, Webster RG, Kelso A, Barr IG, McCauley JW, Daniels RS, Wang D, Shu Y, Nobusawa E, Itamura S, Tashiro M, Harada Y, Watanabe S, Odagiri T, Ye Z, Grohmann G, Harvey R, Engelhardt O, Smith D, Hamilton K, Claes F, Dauphin G.

MBio. 2014 Dec 12;5(6). pii: e02430-14. doi: 10.1128/mBio.02430-14.

3.

Epidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011.

Horm SV, Mardy S, Rith S, Ly S, Heng S, Vong S, Kitsutani P, Ieng V, Tarantola A, Ly S, Sar B, Chea N, Sokhal B, Barr I, Kelso A, Horwood PF, Timmermans A, Hurt A, Lon C, Saunders D, Ung SA, Asgari N, Roces MC, Touch S, Komadina N, Buchy P.

PLoS One. 2014 Oct 23;9(10):e110713. doi: 10.1371/journal.pone.0110713. eCollection 2014.

4.

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.

Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, Arkinstall R, Kelso A, Mcvernon J, Barr IG, Middleton D, Hurt AC.

J Antimicrob Chemother. 2014 Sep;69(9):2458-69. doi: 10.1093/jac/dku146. Epub 2014 May 19.

5.

Detection of evolutionarily distinct avian influenza a viruses in antarctica.

Hurt AC, Vijaykrishna D, Butler J, Baas C, Maurer-Stroh S, Silva-de-la-Fuente MC, Medina-Vogel G, Olsen B, Kelso A, Barr IG, González-Acuña D.

MBio. 2014 May 6;5(3):e01098-14. doi: 10.1128/mBio.01098-14.

6.

TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses.

Carolan LA, Butler J, Rockman S, Guarnaccia T, Hurt AC, Reading P, Kelso A, Barr I, Laurie KL.

J Virol Methods. 2014 May 4;205C:38-52. doi: 10.1016/j.jviromet.2014.04.014. [Epub ahead of print]

7.

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses.

Leang SK, Kwok S, Sullivan SG, Maurer-Stroh S, Kelso A, Barr IG, Hurt AC.

Influenza Other Respir Viruses. 2014 Mar;8(2):135-9.

8.

Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.

Butler J, Hooper KA, Petrie S, Lee R, Maurer-Stroh S, Reh L, Guarnaccia T, Baas C, Xue L, Vitesnik S, Leang SK, McVernon J, Kelso A, Barr IG, McCaw JM, Bloom JD, Hurt AC.

PLoS Pathog. 2014 Apr 3;10(4):e1004065. doi: 10.1371/journal.ppat.1004065. eCollection 2014 Apr.

9.

Epigenetic plasticity of Cd8a locus during CD8(+) T-cell development and effector differentiation and reprogramming.

Harland KL, Day EB, Apte SH, Russ BE, Doherty PC, Turner SJ, Kelso A.

Nat Commun. 2014 Mar 28;5:3547. doi: 10.1038/ncomms4547.

10.

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.

Barr IG, Russell C, Besselaar TG, Cox NJ, Daniels RS, Donis R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Schultz-Cherry S, Shu Y, Smith D, Tashiro M, Wang D, Webby R, Xu X, Ye Z, Zhang W; Writing Committee of the World Health Organization Consultation on Northern Hemisphere Influenza Vaccine Composition for 2013–2014.

Vaccine. 2014 Aug 20;32(37):4713-25. doi: 10.1016/j.vaccine.2014.02.014. Epub 2014 Feb 28.

11.

Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.

McVernon J, Laurie K, Faddy H, Irving D, Nolan T, Barr I, Kelso A.

Influenza Other Respir Viruses. 2014 Mar;8(2):194-200. doi: 10.1111/irv.12225. Epub 2013 Dec 31.

12.

Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region.

Members of the Western Pacific Region Global Influenza Surveillance Response System, Dwyer D, Barr I, Hurt A, Kelso A, Reading P, Sullivan S, Buchy P, Yu H, Zheng J, Shu Y, Wang D, Lam, Aguon A, Oliva RQ, Odagiri T, Tashiro M, Verasahib K, Yusof MA, Nymadawa P, Alexander B, Gourinat AC, Grangeon JP, Jennings L, Huang S, Horwood P, Lucero M, Roque V Jr, Lee Suy L, Cardon P, Tandoc A 3rd, Olveda RM, Kang C, Young-Joon P, Cutter J, Lin R, Low C, Mai le TQ, Balish A, Kile J, Mei S, Mcfarland J, Moen A, Olsen S, Samaan G, Xiyan X, Chea N, Diorditsa S, Feldon K, Fox K, Jamsran M, Konings F, Lewis HC, McPherson M, Nilles E, Olowokure B, Partridge J.

Western Pac Surveill Response J. 2013 Mar 3;4(3):51-9. doi: 10.5365/WPSAR.2013.4.1.009. eCollection 2013 Jul-Sep.

13.

Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides.

Valkenburg SA, Quiñones-Parra S, Gras S, Komadina N, McVernon J, Wang Z, Halim H, Iannello P, Cole C, Laurie K, Kelso A, Rossjohn J, Doherty PC, Turner SJ, Kedzierska K.

Nat Commun. 2013;4:2663. doi: 10.1038/ncomms3663.

PMID:
24173108
14.

Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore.

Chen MI, Cook AR, Lim WY, Lin R, Cui L, Barr IG, Kelso A, Chow VT, Leo YS, Hsu JP, Shaw R, Chew S, Yap JK, Phoon MC, Koh HW, Zheng H, Tan L, Lee VJ.

Influenza Other Respir Viruses. 2013 Nov;7(6):1380-9. doi: 10.1111/irv.12129. Epub 2013 Jul 5.

PMID:
23829633
15.

A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013.

Baas C, Barr IG, Fouchier RA, Kelso A, Hurt AC.

Euro Surveill. 2013 May 23;18(21). pii: 20487. No abstract available.

16.

The use of pyrosequencer-generated sequence-signatures to identify the influenza B-lineage and the subclade of the B/Yamataga-lineage viruses from currently circulating human influenza B viruses.

Deng YM, Iannello P, Caldwell N, Jelley L, Komadina N, Baas C, Kelso A, Barr IG.

J Clin Virol. 2013 Sep;58(1):94-9. doi: 10.1016/j.jcv.2013.04.018. Epub 2013 May 18.

PMID:
23692962
17.

Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.

Guarnaccia T, Carolan LA, Maurer-Stroh S, Lee RT, Job E, Reading PC, Petrie S, McCaw JM, McVernon J, Hurt AC, Kelso A, Mosse J, Barr IG, Laurie KL.

PLoS Pathog. 2013;9(5):e1003354. doi: 10.1371/journal.ppat.1003354. Epub 2013 May 9.

18.

Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient.

Hurt AC, Leang SK, Tiedemann K, Butler J, Mechinaud F, Kelso A, Downie P, Barr IG.

Influenza Other Respir Viruses. 2013 Nov;7(6):904-8. doi: 10.1111/irv.12108. Epub 2013 Mar 29.

PMID:
23551973
19.

Interleukin-4-induced loss of CD8 expression and cytolytic function in effector CD8 T cells persists long term in vivo.

Olver S, Apte SH, Baz A, Kelso A, Kienzle N.

Immunology. 2013 Jun;139(2):187-96. doi: 10.1111/imm.12068.

20.

Influenza antiviral resistance in the Asia-Pacific region during 2011.

Leang SK, Deng YM, Shaw R, Caldwell N, Iannello P, Komadina N, Buchy P, Chittaganpitch M, Dwyer DE, Fagan P, Gourinat AC, Hammill F, Horwood PF, Huang QS, Ip PK, Jennings L, Kesson A, Kok T, Kool JL, Levy A, Lin C, Lindsay K, Osman O, Papadakis G, Rahnamal F, Rawlinson W, Redden C, Ridgway J, Sam IC, Svobodova S, Tandoc A, Wickramasinghe G, Williamson J, Wilson N, Yusof MA, Kelso A, Barr IG, Hurt AC.

Antiviral Res. 2013 Feb;97(2):206-10. doi: 10.1016/j.antiviral.2012.12.016. Epub 2012 Dec 25.

PMID:
23274624
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk